“Poly-ε-caprolactone microspheres containing interferon alpha as alternative formulations for the treatment of chronic hepatitis C”, Braz. J. Pharm. Sci., vol. 48, no. 1, pp. 51–59, Mar. 2012, doi: 10.1590/S1984-82502012000100006.